IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.168
EU - Europa 9.866
AS - Asia 8.928
SA - Sud America 1.853
Continente sconosciuto - Info sul continente non disponibili 762
AF - Africa 232
OC - Oceania 25
Totale 37.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.162
SG - Singapore 4.193
IE - Irlanda 1.766
UA - Ucraina 1.715
RU - Federazione Russa 1.584
BR - Brasile 1.423
HK - Hong Kong 1.344
IT - Italia 1.240
CN - Cina 1.012
SE - Svezia 870
VN - Vietnam 857
DE - Germania 620
CA - Canada 583
FR - Francia 570
FI - Finlandia 550
GB - Regno Unito 404
KR - Corea 272
TR - Turchia 194
IN - India 190
BD - Bangladesh 152
AR - Argentina 131
IQ - Iraq 101
PL - Polonia 88
MX - Messico 85
UZ - Uzbekistan 83
CO - Colombia 78
EC - Ecuador 76
CH - Svizzera 70
AT - Austria 68
CR - Costa Rica 61
ID - Indonesia 60
NL - Olanda 60
PK - Pakistan 60
SA - Arabia Saudita 60
ZA - Sudafrica 56
JP - Giappone 53
GT - Guatemala 46
HN - Honduras 44
PH - Filippine 44
ES - Italia 42
CW - ???statistics.table.value.countryCode.CW??? 40
VE - Venezuela 40
LB - Libano 34
CZ - Repubblica Ceca 32
PR - Porto Rico 32
PY - Paraguay 31
BE - Belgio 30
NI - Nicaragua 30
RO - Romania 30
CL - Cile 28
GR - Grecia 27
MA - Marocco 27
IL - Israele 26
MY - Malesia 26
TN - Tunisia 26
TT - Trinidad e Tobago 26
KE - Kenya 23
AE - Emirati Arabi Uniti 22
PE - Perù 22
SV - El Salvador 22
JM - Giamaica 21
LT - Lituania 21
PT - Portogallo 21
EG - Egitto 20
JO - Giordania 19
NP - Nepal 19
AU - Australia 17
GP - Guadalupe 17
DZ - Algeria 15
DO - Repubblica Dominicana 14
EU - Europa 14
AM - Armenia 13
UY - Uruguay 13
BG - Bulgaria 12
KZ - Kazakistan 12
OM - Oman 12
SC - Seychelles 12
BO - Bolivia 10
ET - Etiopia 10
PA - Panama 8
SN - Senegal 8
TW - Taiwan 8
BH - Bahrain 7
DK - Danimarca 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
AZ - Azerbaigian 5
BB - Barbados 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
BF - Burkina Faso 4
EE - Estonia 4
GE - Georgia 4
HU - Ungheria 4
LU - Lussemburgo 4
PS - Palestinian Territory 4
RS - Serbia 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
Totale 37.041
Salva come PNG Salva come JPEG
Città #
Singapore 2.763
Dublin 1.764
Chandler 1.692
Hong Kong 1.335
San Jose 1.190
Ashburn 1.186
San Mateo 1.102
Jacksonville 770
Boardman 658
Santa Clara 597
Council Bluffs 550
Princeton 496
Dong Ket 489
Medford 489
Moscow 468
Lauterbourg 425
Wilmington 369
Altamura 362
Andover 345
Lawrence 284
Perugia 274
Ottawa 268
Seoul 268
Ann Arbor 242
New York 176
Beijing 172
Los Angeles 168
São Paulo 163
Ho Chi Minh City 144
Des Moines 139
Saint Petersburg 130
Piscataway 124
The Dalles 111
Norwalk 108
Izmir 106
Dallas 104
Helsinki 94
Shanghai 89
Munich 84
Columbus 69
Hanoi 67
Montreal 67
Rome 62
Chicago 58
Rio de Janeiro 58
Falls Church 55
North Bergen 55
San Paolo di Civitate 54
Phoenix 51
Milan 50
San José 50
Brooklyn 49
Warsaw 49
Orem 48
London 44
Baghdad 43
Tokyo 43
Atlanta 42
Frankfurt am Main 40
Toronto 40
Woodbridge 40
Willemstad 39
Houston 36
Brasília 35
Chennai 35
Guatemala City 35
Tashkent 35
Nuremberg 34
Turku 33
Belo Horizonte 32
Bogotá 32
Johannesburg 31
Redwood City 31
Denver 30
Managua 29
Brussels 28
San Diego 28
San Francisco 28
Buffalo 27
Naples 27
Stockholm 26
Amelia 25
Quito 25
Guangzhou 24
Amsterdam 22
Boston 22
Dearborn 22
Guayaquil 22
Salvador 22
Bucharest 21
Curitiba 21
Goiânia 21
Istanbul 21
Jeddah 21
Lahore 21
Manchester 21
Mexico City 21
Redmond 21
San Salvador 20
Ankara 19
Totale 22.475
Salva come PNG Salva come JPEG
Nome #
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 202
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 181
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 175
Interventions for enhancing medication adherence. 174
1286 Prospective consecutive cases of venous thromboembolic diseases at the single Venous thromboembolic Unit of Reggio Emilia 173
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 154
Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries 142
Sindrome da anticorpi fosfolipidi. Descrizione di un caso clinico con trombosi atriale dx e revisione della casistica di Reggio Emilia 138
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 137
Serine base exchange enzyme in commercially available porcine lyophilised platelets: different effect of unfractionated and low molecular weight heparins 137
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 137
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 137
Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo0-SatA) 137
. The role of thrombophilic states in the bleeding tendency of patients with hemophilia 136
Influenza vaccination in patients on long-term anticoagulant therapy 133
Influenza vaccination in patients on long-term anticoagulant therapy. 128
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation 128
GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks 126
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 125
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 124
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 124
D-DIMER TO PREDICT THROMBOSIS RECURRENCE: COMPARISON OF AGGREGATE DATA AND INDIVIDUAL PATIENT DATA META-ANALYSES. 124
Le trombofilie acquisite 123
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 123
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 123
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. 123
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 123
L’organizzazione del centro per il monitoraggio della terapia anticoagulante orale 121
D-DIMER TO PREDICT THROMBOSIS RECURRENCE AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: EFFECT OF PATIENT- AND D-DIMER-RELATED FACTORS ON RECURRENCE PREDICTION 121
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 119
A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study. 119
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 118
Sustained suppression of hepatitics C by pegylated Interferon (PEG-INF) and Ribavirin in hemophilic patients 117
Profilassi della trombosi venosa profonda in neurochirurgia 116
Systematic Review of Randomized Controlled Trials of Prophilactic Clotting Factor Concentrate in Hemophilia 116
Thrombophilia and cerebral vein thrombosis 116
Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward. 116
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulant 115
ACP Journal Club. A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 114
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 114
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients 114
Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins 113
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project 112
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls 112
Venous thromboembolic disease: clinical reatures of 1282 prospective consecutive cases at angiology unit of Reggio Emilia 111
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 110
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 110
Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study 110
Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen 110
Prothrombin 202120A mutation in Behcet’s disease 109
Elderly patients treated with oral anticoagulant: a prospective cohort study 109
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents 109
I disordini congeniti ed acquisiti dell’emostasi e della fibrinolisi 108
D-Dimer Testing to Determine the Duration of Anticoagulation Therapy 108
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. 108
Il monitoraggio della terapia anticoagulante orale 107
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 107
Low-molecular-weight-heparin treatment and cancer: pooled analysis of 908 patients treated for three months and review of the literature 106
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 106
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 106
Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia a patients carrying f8 gene null mutations. 106
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 106
Studio GEMINA: ruolo dei polimorfismi genetici e dell'omocisteinemia nell'infarto del miocardico in giovani-adulti italiani 105
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. 105
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 105
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 105
D-DIMER TO PREDICT RECURRENCE AFTER A FIRST EPISODE OF UNPROVOKED VENOUS THROMBOEMBOLISM: COMPARISON OF AGGREGATE AND INDIVIDUAL PATIENT DATA META-ANALYSIS 105
A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease 105
Ecaps study: multicentric evaluation of cerebral hemorrhage in anticoagulated/antiaggregated patients in the italian emergency rooms 104
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 104
The good use of plasma. A critical analysis of five international guidelines. 104
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY 103
Risk factors for venous thromboembolism in patients undergoing elective neurosurgery 102
Thrombotic risk and laboratory pattern in 91 consecutive patients with lupus anticoagulant and/or anticardiolipin antibodies 102
Eradicazione del virus C dell'epatite (HCV) dopo terapia combinata con Interferone Pegilato (PEG-INF) e Rivabirina in pazienti emofilici HIV negativi 102
Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases 102
Different mechanism regulate phosphatidylserine synthesis in rat cerebral cortex" 102
Switching patients in the age of long-acting recombinant products? 102
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 101
Oral Anticoagulants and small intestinal bacterial overgrowth 101
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 101
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome 101
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A 101
APTT evaluation in the presurgery screening: survey of 5000 patients 100
Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients 100
Venous thrombotic risk assessment among factor V Leiden carriers undergone a thrombophilic screening by different types of indications 100
Utilizzo di AGREE per l’analisi delle linee guida (LG) internazionali sul buon uso del plasma. 100
The association between platelet transfusions and mortality in patients with critical illness 100
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 99
ACP Journal Club. The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 99
Indoleamina 2,3 diossigenasi e tolleranza al fattore VIII in pazienti affetti da emofilia a grave. 99
Inhibition of fluid phase and fibrin bound thrombin: effect of heparin, r-hirudin, PEG-rm-hirudin and a thrombin exosite inhibitor 98
Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony) 98
Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study 98
Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest 98
Low-molecular-weight heparin and cancer survival: pooled analysis of 1726 patients treated for three months 97
Genima study: genetic polymorphysms and myocardial infarction among italian young adults 97
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 97
Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies 97
Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study. 97
Totale 11.542
Salva come PNG Salva come JPEG
Categoria #
all - tutte 183.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.715 0 0 0 0 123 36 64 1.372 34 25 445 616
2022/20235.912 541 887 95 415 472 660 8 302 2.251 10 193 78
2023/20242.084 157 229 108 36 36 14 507 125 211 82 238 341
2024/20255.072 20 621 63 140 714 106 88 419 1.145 344 1.009 403
2025/202610.285 786 573 628 1.433 1.025 1.040 1.961 581 1.029 901 242 86
2026/20273.906 171 301 605 2.470 359 0 0 0 0 0 0 0
Totale 37.834